Charlottesville County, Va., funds by Health and Human Services, Department of
Listing $58,219,492.70 in stimulus funds from Health and Human Services, Department of for Charlottesville
Note: For some programs where states do not report where money will be distributed across the state, we do not have the allocation for individual counties. Those programs include: Medicaid, unemployment benefits and food stamps. Those amounts are included in the totals for where the state agency receiving that money is located.
Amount refers to both the amount of stimulus funding going toward the project and the face value of the loan.
| Recipient | Amount | Description | Federal Dept./Agency | Date |
|---|---|---|---|---|
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $4,071,147 |
Trans-NIH Recovery Act Research Support It is estimated that 3.2 million African Americans aged 20 years or older have T2DM. This represents approximately 13 percent of the AA population and a significant proportion of the more than 20 million Americans believed to be living with diabetes, a di
This spending item is part of a $4,254,196 allocation.
See details
|
National Institutes of Health | 7/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $3,527,236 | Trans-NIH Recovery Act Research Support Conducting timely, high quality, comparative effectiveness research (CER) and creating and delivering recommendations for genomic tests in cancer care and prevention are major technical and intellectual challenges. Yet with the increased use of Electronic | National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $2,310,000 | Trans-NIH Recovery Act Research Support Mammalian genomes have a complex physical structure shaped by myriad duplications, deletions and rearrangements, and this structure varies considerably among the populations and individuals of a species. These 'structural variations' are of special import | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $2,040,641 | Trans-NIH Recovery Act Research Support This G20 proposal from the University of Virginia School of Medicine (UVA SOM) requests $2.1 M to upgrade and consolidate the UVA SOM electron microscopy (EM) resources into a Molecular Electron Microscopy Core (MEMC) facility. We estimate that the associ | National Institutes of Health | 3/25/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $2,000,000 | Trans-NIH Recovery Act Research Support Funds are requested for purchase of a state-of-the-art 300 keV liquid helium Transmission Electron Cryo-Microscope with a Field Emission Gun. To leverage the funds provided by this NIH program, approximately 40% of the funds for this microscope will be de | National Institutes of Health | 4/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,851,073 |
Trans-NIH Recovery Act Research Support Neonatal apnea, or apnea of prematurity, is the most common serious disorder of premature infants in the neonatal intensive care unit (NICU). There are significant gaps in knowledge in its definition, documentation and management. For example, despite con
This spending item is part of a $2,021,390 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,786,346 |
Trans-NIH Recovery Act Research Support Genome-wide association (GWA) studies have made great progress in the identification of regions that are likely to contain genetic variants contributing to the risk of cardiovascular, lung and blood diseases. Despite these successes, variants identified t
This spending item is part of a $2,343,137 allocation.
See details
|
National Institutes of Health | 9/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,475,182 | Trans-NIH Recovery Act Research Support This application is in response to the NCI ARRA RFA 'Request for New Faculty Supplemental Award.' The parent grant for this award is P30 CA44579. The University of Virginia Cancer Center seeks to recruit physician-scientists who can link its strengths in | National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,396,043 | Trans-NIH Recovery Act Research Support Peripheral arterial disease (PAD) is characterized by lower limb arterial obstruction due to atherosclerosis that impairs blood flow to the lower limb. PAD is quite common with over 8 million affected individuals in the U.S. Over the past 6 years, our mul | National Institutes of Health | 7/16/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,009,890 | Trans-NIH Recovery Act Research Support Atherosclerosis is a chronic disease characterized by lipid infiltration and inflammatory cell recruitment in the vessel wall that can lead to serious clinical consequences such as myocardial infarction and stroke. While of the role of monocytes and T lym | National Institutes of Health | 8/31/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,000,000 | Trans-NIH Recovery Act Research Support This application addresses Broad Challenge Area (08): Genomics and specific Challenge Topic, 08-HL-104: Assess Genetic Variation in African Americans and determine its effect on disease. Coronary artery disease (CAD) is a leading cause of death worldwide | National Institutes of Health | 9/23/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $1,000,000 | Trans-NIH Recovery Act Research Support The goal of our project is to develop vaccine strategies that will target viral pathogens underlying the most common AIDS malignancies even in the unfavorable immunologic setting of low CD4+ T cell counts that typically characterizes HIV-infected patients | National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $999,999 | Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (15) Translational Science and specific Challenge Topic, 15-DE-101 Molecular Profiling and Developing Mouse Models for Salivary Gland Tumor Research. The proposed work will expand an ongoing successful resea | National Institutes of Health | 9/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $987,722 | Trans-NIH Recovery Act Research Support The peripheral chemoreceptors (carotid bodies) detect changes in blood oxygen and / or pH whereas central chemoreceptors detect changes in brain extracellular fluid pH. When activated, these receptors produce a large spectrum of effects that include the s | National Institutes of Health | 6/01/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $927,077 |
Trans-NIH Recovery Act Research Support This application addresses Broad Challenge Area (12) Science, Technology, Engineering and Mathematics Education and specific challenge area 12-OD-101, Efficacy of educational approaches toward promoting STEM competencies. The title of the proposal is Impr
This spending item is part of a $998,119 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $911,875 | Trans-NIH Recovery Act Research Support Challenge Area: 06 Enabling Technologies. Specific Challenge Topic: 06-GM-101 Structural Analysis of Macromolecular Complexes. A major challenge in chromatin biology and molecular cytology is how to study the macromolecular structures of specific epigenet | National Institutes of Health | 9/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $910,983 | Trans-NIH Recovery Act Research Support Following myocardial infarction, the mechanical properties of the healing scar are a critical determinant of left ventricular function, infarct expansion, aneurysm formation and rupture, and ventricular remodeling. Until recently, the only therapeutic opt | National Institutes of Health | 6/01/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $896,912 | Trans-NIH Recovery Act Research Support The renin-angiotensin system (RAS) is a hormonal cascade of major critical importance to the regulation of blood pressure, fluid and electrolyte balance and kidney function. Angiotensin II (Ang II), the main effector peptide of the RAS, acts at two major | National Institutes of Health | 7/16/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $810,015 | Trans-NIH Recovery Act Research Support Cyclic AMP is a highly versatile second messenger in the heart, transducing an array of different receptor stimuli into coordinated regulation of cardiac functions including excitation-contraction (EC) coupling and gene transcription. But how cAMP can sel | National Institutes of Health | 6/04/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $770,000 | Trans-NIH Recovery Act Research Support Epilepsy affects about 2.5 million people in the United States. If not properly controlled by antiepileptic drugs, seizure disorders can lead to lower quality of life and loss of productivity. One class of epilepsy is called idiopathic generalized epileps | National Institutes of Health | 9/20/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $770,000 | Trans-NIH Recovery Act Research Support Our primary objective is to obtain further information about the mechanisms of acute episodes of asthma both in adults and children. This requires knowing details of the patients, including exhaled nitric oxide (FeNO), exhaled breath pH, eosinophilia, and | National Institutes of Health | 9/11/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $770,000 | Trans-NIH Recovery Act Research Support Temporal lobe epilepsy (TLE) is a common form of medically refractory epilepsy characterized by recurrent unprovoked seizures involving the limbic structures, which often requires surgery. Multiple pathophysiological mechanisms have been proposed to expla | National Institutes of Health | 7/20/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $755,380 | Trans-NIH Recovery Act Research Support Work done in many laboratories has demonstrated that Ag stimulation of naive CD8 T cells can lead to different outcomes: development into effector cells and/or memory cells after immunogenic stimulation, and either activation and deletion or anergy in rel | National Institutes of Health | 5/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $730,749 | Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (06) Enabling Technologies and specific Challenge Topic, 06-HL-105: Develop transgenic animal models that are informative for understanding chronic inflammation in humans. Chronic noncommunicable diseases (C | National Institutes of Health | 9/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $691,831 | Trans-NIH Recovery Act Research Support Congenital obstructive nephropathy is the most important identifiable cause of renal impairment in infants and children. Despite this, indications for surgical intervention are controversial, and renal recovery is often disappointing. While mechanisms res | National Institutes of Health | 8/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $690,666 | Trans-NIH Recovery Act Research Support One of NIDA's highest priorities for funding is the development of effective pharmacotherapies for substance related disorders. In response to RFA-DA-09-005, soliciting pilot clinical/human studies of interventions that specifically target mechanisms kno | National Institutes of Health | 7/16/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $671,415 | Trans-NIH Recovery Act Research Support This application addresses broad Challenge Area (05): Comparative Effectiveness Research and specific Challenge Topic: 05-AA-102 Adaptive Designs and Person-Centered Data Analysis for Alcohol Treatment Research. As the challenge topic implies, statistical | National Institutes of Health | 9/25/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $616,000 | Trans-NIH Recovery Act Research Support Spermatogenesis is a complex process where the proliferation/differentiation of germ cells is intimately tied to their apoptosis. How these germ cell corpses are cleared and how this engulfment process links to normal spermatogenesis, are poorly understoo | National Institutes of Health | 7/24/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $556,784 | Trans-NIH Recovery Act Research Support Lung cancer is the number one cancer killer in the United States, exceeding breast, colorectal, prostate, and melanoma malignancies combined. Of all newly diagnosed lung cancers, greater than eighty percent of these malignancies are non-small cell lung ca | National Institutes of Health | 6/05/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $500,000 | Trans-NIH Recovery Act Research Support The objective of this NCRR Shared Instrument Grant application is to obtain funding to purchase a Thermo Electron Orbitrap XL-ETD mass spectrometer for the W.M. Keck Biomedical Mass Spectrometry Lab (MS Core) at the University of Virginia's School of Medi | National Institutes of Health | 4/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $500,000 | Trans-NIH Recovery Act Research Support Funds are requested to upgrade an existing commercial Bruker Elexsys 500 continuous wave EPR spectrometer to add pulse capability. The upgraded instrument will be a highly versatile EPR instrument that will be capable of a broad range of pulse experiments | National Institutes of Health | 2/04/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $498,925 | Trans-NIH Recovery Act Research Support The University of Virginia School of Medicine currently has an obsolete 40-year-old orthovoltage XRAY machine which is used for irradiation of small animals. This proposal is to replace our obsolete irradiator with a state of the art small animal radiatio | National Institutes of Health | 12/09/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $482,451 | Trans-NIH Recovery Act Research Support Funds are requested to purchase a VisualSonics Vev02100 phased array small animal ultrasound imaging system - including transducers appropriate for cardiovascular, cancer, nephrology and diabetes research. High resolution ultrasound is the preferred modal | National Institutes of Health | 12/09/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $450,960 | Trans-NIH Recovery Act Research Support This instrumentation request is to purchase a new four-channel NMR console to be used in conjunction with an existing 11.7 T narrow bore super conducting magnet to create a new spectrometer capable of state-of-the-art NMR experiments on solid samples. Thr | National Institutes of Health | 2/20/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $431,200 | Trans-NIH Recovery Act Research Support Our laboratory has been funded for ~30 years by RO1-GM26108 to investigate the mechanisms of replication control in mammalian chromosomes. We identified the first origin of replication, which lies downstream from the DHFR gene in Chinese hamster cells. | National Institutes of Health | 7/16/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $423,500 | Trans-NIH Recovery Act Research Support The epithelium separates the vast array of luminal antigens from the underlying gastrointestinal tissue and in this position, it serves as the first site to encounter many pathogens. Epithelial cells emerge from stem cells from the deeper layers of the gl | National Institutes of Health | 9/01/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $416,211 | Trans-NIH Recovery Act Research Support Bacillus anthracis is the bacterium that causes the disease anthrax. Concern over its use as a bioweapon has renewed interest in elucidating mechanisms of how it causes disease. B. anthracis promotes its growth in the host through the production of lethal | National Institutes of Health | 5/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $413,535 | Trans-NIH Recovery Act Research Support This research project involves studying naturally occurring IgM autoantibodies that bind to leucocytes (IgM-ALA). Hypothesis: We propose that IgM-ALA provide an innate mechanism to inhibit inflammatory processes as for example that observed in many kidney | National Institutes of Health | 6/22/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $404,601 | Trans-NIH Recovery Act Research Support The long-term objective of this work is to develop predictable and reproducible therapies for soft tissue regeneration using adipose stem cells (ASCs) formulated as 3-dimensional (3-D) multicellular aggregates. Currently available treatments are limited b | National Institutes of Health | 5/27/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $403,750 | Trans-NIH Recovery Act Research Support Francisella tularensis is a highly efficient zoonotic pathogen that is able to establish a virulent infection with 10 organisms or less. To accomplish this feat the bacterium must have devised efficient means of infecting its host, and effective ways of a | National Institutes of Health | 5/07/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $398,417 | Trans-NIH Recovery Act Research Support The goal of this project is the prototype development and evaluation of a wireless laboratory animal monitoring system (WLAMS) for the improvement of animal welfare and the direct and real-time monitoring of disease status. The system will consist of thre | National Institutes of Health | 8/07/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $385,700 | Trans-NIH Recovery Act Research Support Many physiological parameters affecting human health and disease, including the sleep/wake cycle, core body temperature, hormonal secretion, cardiovascular function, respiration, and metabolism exhibit daily rhythms that are generated by an internal circa | National Institutes of Health | 4/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $381,137 |
Trans-NIH Recovery Act Research Support Project Narrative Case Western Reserve University with its collaborators at University of Louisville, and University of Minnesota with strong multidisciplinary faculty are conducting studies focused on testing the concept that infusion of C3a primed umbil
This spending item is part of a $785,839 allocation.
See details
|
National Institutes of Health | 2/09/2011 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $378,750 | Trans-NIH Recovery Act Research Support The body's defense system can be divided into two components, the innate and adaptive immune systems. The innate immune system acts as the first line of defense against invading pathogens (e.g., bacteria) and is found in plants and all animals. The respon | National Institutes of Health | 6/04/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $377,129 | Trans-NIH Recovery Act Research Support Fresh fruits and vegetables are indisputable parts of a healthy diet. These foods contain a number of chemical compounds that have been shown to protect against tumor development in animal models of carcinogenesis. Unfortunately, a mechanistic understan | National Institutes of Health | 8/31/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $363,716 | Trans-NIH Recovery Act Research Support Francisella tularensis tularensis is a category A select agent for Biodefense Research. It is a highly efficient zoonotic pathogen that has an infectious dose of 10 organisms or less. To accomplish this feat the bacterium has clearly devised efficient m | National Institutes of Health | 5/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $350,890 | Trans-NIH Recovery Act Research Support We are requesting an administrative supplement to our parent training program, 'A Systems Engineering Focus on Clinical Informatics' to support two predoctoral and one postdoctoral training fellowships for 2 years each, including stipend, tuition, travel | National Institutes of Health | 7/23/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $347,607 | Trans-NIH Recovery Act Research Support This application requests supplemental funding for the parent grant 1 R01 GM081510, SIS Multicenter Study of Duration of Antibiotics for Intraabdominallnfection. The main purpose of these supplemental funds is to hire of an additional research coordinato | National Institutes of Health | 9/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $347,000 | Trans-NIH Recovery Act Research Support The W.M. Keck Center for Cellular Imaging (KCCI), an internationally recognized center for advanced light microscopy imaging that is particularly known for protein-protein interaction imaging, is requesting a Frequency-domain Fluorescence Lifetime Imaging | National Institutes of Health | 5/13/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $346,500 | Trans-NIH Recovery Act Research Support Francisella tularensis tularensis is a category A select agent for Biodefense Research. It is a highly efficient zoonotic pathogen that has an infectious dose of 10 organisms or less. To accomplish this feat the bacterium has clearly devised efficient m | National Institutes of Health | 6/14/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $338,804 | Trans-NIH Recovery Act Research Support This is an application for supplemental funding to support an expanded analysis of influenza-host cell interactions emanating from studies initiated in the Project 1 of the Cooperative Agreement U-19 AI-83024. The proposed analysis will examine the intera | National Institutes of Health | 7/06/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $337,240 | Trans-NIH Recovery Act Research Support Racial and ethnic health disparities abound, with decreased quality of health care in these underserved communities. The reasons for these health inequities are complex and multi-layered. As noted by the Institute of Medicine, there are historic and conte | National Institutes of Health | 6/04/2009 |
| INDOOR BIOTECHNOLOGIES INC | $321,134 | Trans-NIH Recovery Act Research Support The main goal of this supplement is to measure IgE antibody binding to specific cockroach allergens for the Inner City Asthma Consortium. As a result of this analysis, sera will be identified and used to expedite the research performed under the RO1 paren | National Institutes of Health | 6/28/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $290,810 |
Trans-NIH Recovery Act Research Support The project is a supplement to the parent grant R01 CA-122704-02. The goals of this Diversity Supplement project are to develop and pilot test cognitive-behavioral coping skills training (CST) protocols tailored for partnered and unpartnered African Ameri
This spending item is part of a $598,592 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $272,566 |
Trans-NIH Recovery Act Research Support 1) HIV Tropism as a potential Biomarker for Atherosclerosis: This project investigates whether a property of HIV called 'tropism' can predict which HIV-infected individuals are at high risk of developing cardiovascular disease. Identifying such a predi
This spending item is part of a $1,546,761 allocation.
See details
|
National Institutes of Health | 4/28/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $269,500 | Trans-NIH Recovery Act Research Support This proposal describes the development of an innovative training and research tool, a novel agent-based model (ABM), to address a critical global health challenge, the devastating toll of early childhood diarrhea (ECD). An ABM will be developed to simula | National Institutes of Health | 9/26/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $269,009 |
Trans-NIH Recovery Act Research Support This application is in response to Challenge Area 04-HL-104, 'Perform secondary analyses of existing data to answer important clinical and preventive medicine research questions.' The specific topic is #8, 'Analysis of genetic markers related to risk fact
This spending item is part of a $970,456 allocation.
See details
|
National Institutes of Health | 9/18/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $264,975 | Trans-NIH Recovery Act Research Support The overall goal of this supplement to R01AA014356 is to develop and test the remote telephone delivery of a successful intervention that reduces drinking and improves contraception among women at risk for alcohol-exposed pregnancy due to frequent or bing | National Institutes of Health | 8/15/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $260,902 | ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement Objective A: Create an expanded and improved version of our Web-based information system, SPARCv3. This version will be enhanced for use by a broader clinician user base, with additional quality measures, added f functionality, and an improved user Interfac... Show more | Health Resources and Services Administration | 8/20/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $254,764 | Trans-NIH Recovery Act Research Support Aim 1 of the parent grant focused on characterizing the regulation and localization of several catenin proteins as a function of the hemodynamic environment in vitro and in vivo in the context of atherosclerosis. One of our major observations was that p1 | National Institutes of Health | 7/16/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $251,444 | Trans-NIH Recovery Act Research Support The overall goal of this project is to elucidate mechanisms involved in the control of metabolism by insulin in skeletal muscle and fat cells. Both whole animal and cell culture models suggest that significant changes in phospholipid and TAG intermediates | National Institutes of Health | 1/15/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $234,053 | Trans-NIH Recovery Act Research Support This is a supplemental request to the parent grant, Biochemistry and Regulation of Cadherin Activity, that will not add to the scope or specific aims. Rather it will provide funds for the retention of a key person who was listed without salary on the orig | National Institutes of Health | 9/30/2009 |
| ALBEMARLE, COUNTY OF | $233,018 |
ARRA Child Care and Development Block Grant ARRA Supplemental Discretionary Grant Award. The award represents an additional Discretionary fund obligation to the State for fiscal year 2009 for the Child Care Development Fund.
This spending item is part of a $37,891,741 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $232,832 |
Trans-NIH Recovery Act Research Support Our primary objective is to identify specific gene variants that are related to the formation and rupture of intracranial aneurysms (IA). Our experienced collaborative and highly productive team of Familial Intracranial Aneurysm (FIA) Investigators at 27
This spending item is part of a $8,081,413 allocation.
See details
|
National Institutes of Health | 9/14/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $231,000 | Trans-NIH Recovery Act Research Support Over the last 4 years the parent grant (HD 44517) has been focused on improving our understanding of the pathophysiology of anesthesia-induced developmental neurodegeneration so that effective neuroprotective strategies can be developed. Our work, done wi | National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $228,959 | Trans-NIH Recovery Act Research Support This supplement is a request to accelerate and extend the first two aims of the parent project. The production, purification and labeling of TonS dependent transporters is the most labor intensive aspect of the current project, and ongoing work to measure | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $226,376 | Trans-NIH Recovery Act Research Support This application is to request funds to purchase an inverted fluorescence microscope and to employ a postdoctoral associate for 18 months. Both Specific Aims require the extensive use of a fluorescence microscope. Currently, our access to a fluorescence m | National Institutes of Health | 7/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $221,427 | ARRA Grants for Training in Primary Care Medicine and Dentistry Training and Enhancement Enhancing the Culturally Competent Care of Vulnerable Populations: Global Health in Your Own Back Yard There are increasing subsets of children, elderly, immigrant and refugee, and persons with HIV/AIDS who haveve difficulty obtaining care or are limited b... Show more | Health Resources and Services Administration | 7/15/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $218,661 | Trans-NIH Recovery Act Research Support The long term goal of the original project is to understand how the functions of nuclear transport factors and histone chaperones are coordinated, and regulate the assembly of histones into specific chromatin domains. This project focuses on the role of h | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $203,250 | Trans-NIH Recovery Act Research Support Funds are requested to purchase an atomic force microscope (AFM) in order to establish the Core Laboratory for Biomedical Applications of Atomic Force Microscopy at the University of Virginia. The instrument purchased will be the Multimode V Scanning Pro | National Institutes of Health | 5/13/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $197,673 | Trans-NIH Recovery Act Research Support The broad, long-term objective of the proposed project is to elucidate the catalytic mechanism of Mot1, a prototypical member of the Snf2/Swi2 ATPase family. Mot1 is an essential, conserved transcription factor that uses ATP hydrolysis to dissociate TATA | National Institutes of Health | 9/09/2009 |
| CITY OF CHARLOTTESVILLE | $195,354 |
ARRA Child Care and Development Block Grant ARRA Supplemental Discretionary Grant Award. The award represents an additional Discretionary fund obligation to the State for fiscal year 2009 for the Child Care Development Fund.
This spending item is part of a $37,891,741 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $189,000 | Trans-NIH Recovery Act Research Support Very low birth weight [VLBW] infants have an increased risk of brain injury [BI] and consequently, are more likely to exhibit signs of motor, cognitive, or behavioral impairment. Studies have examined the effects of Apolipoprotein E (APOE) genotype on out | National Institutes of Health | 9/09/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $183,571 | Trans-NIH Recovery Act Research Support This project is an extension of parent grant DC05439 entitled Ion channel function in auditory and vestibular hair cells. For the supplement we propose to extend these studies to examine the role of a class of ion channels genes in hair cells. The hair c | National Institutes of Health | 7/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $181,674 | Trans-NIH Recovery Act Research Support Glutamate transporters (EAATs) play an important role in the regulation of extracellular levels of glutamate, a major excitatory neurotransmitter in the central nervous system. Current data show that glutamate transporter type 3 (EAAT3) in the hippocampus | National Institutes of Health | 7/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $177,500 | Trans-NIH Recovery Act Research Support This is a supplemental request to the parent grant, Catenin & Cadherin Signaling in Development and Cancer, that will not add to the scope or specific aims. Rather it will provide funds for the retention of key personnel whose positions were supported by | National Institutes of Health | 1/22/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $176,047 | Trans-NIH Recovery Act Research Support The focus of our original submission was on the use of NMR spectroscopy to determine the structure and understand the mechanism of the integral membrane enzyme DsbB. Four aims were included in the funded grant: Aim 1: Determination of the solution structu | National Institutes of Health | 1/29/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $173,589 | Trans-NIH Recovery Act Research Support This project award will retain a pre-doctoral graduate student (FTE). The overall aim of the parent grant (PG, HL081682) proposal is to determine the mechanisms by which calcium (Ca) signaling differentially regulates vascular smooth muscle cell (SMC) phe | National Institutes of Health | 7/16/2009 |
| CHILDREN YOUTH & FAMILY SERVICE | $168,758 |
ARRA Child Care and Development Block Grant ARRA Supplemental Discretionary Grant Award. The award represents an additional Discretionary fund obligation to the State for fiscal year 2009 for the Child Care Development Fund.
This spending item is part of a $37,891,741 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $165,589 | Trans-NIH Recovery Act Research Support A major part of our parent grant is to fine map the Ckdbp2 locus (CKD blood pressure locus 2) and identify gene(s) conferring susceptibility to hypertension after loss of nephron mass. In this supplement, we propose to use a multi-level approach for candi | National Institutes of Health | 1/15/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $160,791 | Trans-NIH Recovery Act Research Support Preliminary studies have led to the discovery that the redox modulatory site is part of a high affinity metal binding site site on the extracellular face of the Cav3.2 T-type channel. Endogeneous levels of trace metals are high enough to fill this site an | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $158,877 | Trans-NIH Recovery Act Research Support Gene manipulation in vivo using transgenic or targeted gene deletion can result in embryonic lethality, developmental defects or compensation by other gene products, all of which confound interpretation of normal gene function. Alternate strategies have b | National Institutes of Health | 7/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $154,000 | Trans-NIH Recovery Act Research Support Over the past 20 years we developed Blood Glucose Awareness Training (BGAT), an 8-session intervention that focuses on preventing extreme blood glucose (BC), and better detection and management of extreme BG when it occurs. BGAT has broad benefits: reduc | National Institutes of Health | 3/29/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $148,204 | Trans-NIH Recovery Act Research Support For children between the ages of 3 and 5, their readiness to function competently in school is best understood in terms of the nature and quality of their interactions in classrooms with adults, with peers, and with learning/instructional activities. Clas | National Institutes of Health | 8/10/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $144,039 | Trans-NIH Recovery Act Research Support This request for an ARRA Administrative Supplement is designed to accelerate the science funded by the parent grant entitled Neural Plasticity in the Adult Gustatory System (# ROl DC006938). The primary aim of the supplement is to accelerate our new work | National Institutes of Health | 7/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $141,850 | Trans-NIH Recovery Act Research Support In our grant application, as part of Aim 2, we had proposed to study the role of SHP-1 in CD4+CD25+Foxp3+regulatory T cells. These studies have resulted in some very interesting findings not only defining a role for SHP-1 in Treg cells, but also addressi | National Institutes of Health | 9/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $130,761 |
Trans-NIH Recovery Act Research Support The goals of this study are to demonstrate and confirm the role of genetic factors in the development of chronic otitis media with effusion and recurrent otitis media (COME/ROM) to improve understanding of its underlying biological and pathological mechan
This spending item is part of a $246,636 allocation.
See details
|
National Institutes of Health | 7/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $125,001 | Trans-NIH Recovery Act Research Support A prevalent neuromodulatory mechanism involves G protein-coupled receptors that link via Gqjll a subunits (GaqPCRs) to inhibit background K+ channels, evoking depolarization and increased neuronal excitability. Our work has focused on GaqPCR modulation of | National Institutes of Health | 8/11/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $121,377 | Trans-NIH Recovery Act Research Support 1. Purpose of the supplement - This is a request for salary support for a postdoctoral research associate to continue work begun on this project by a former postdoctoral fellow. The former postdoctoral fellow was a vital component of our current NIGMS-fun | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $120,562 | Trans-NIH Recovery Act Research Support The administrative supplement will be used to carryout a highly sensitized screen using transgene based RNAi to identify additional genes whose function is required for the development of planar polarity in the Drosophila epidermis. The basic approach of | National Institutes of Health | 7/17/2009 |
| LUNA INNOVATIONS INCORPORATED | $117,974 | Trans-NIH Recovery Act Research Support Leptospirosis, an infection resulting from skin or mucous membrane contact with urine of infected animals, is considered the most common zoonosis worldwide. It is estimated to affect tens of millions annually with mortality rates ranging from 5 to 25%. Le | National Institutes of Health | 8/02/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $115,614 | Trans-NIH Recovery Act Research Support Controlling transcription factor activity by regulating nuclear and cytoplasmic localization is an important and evolutionarily conserved mechanism. Members of the nuclear receptor (NR) super-family of ligand-regulated transcription factors undergo cycles | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $114,990 | Trans-NIH Recovery Act Research Support To define the mechanism by which early inflammatory cell recruitment is accelerated in males during AAA formation. To demonstrate that gonadal hormones can be used to modulate the inflammatory response accompanying AAA formation. | National Institutes of Health | 12/22/2010 |
| EMPIRICAL TECHNOLOGIES CORP | $113,956 | Trans-NIH Recovery Act Research Support Falls among the elderly, one of the most common reasons requiring medical intervention and a contributing factor in 40% of nursing home admissions, are a major health problem. Several studies have identified quantifiable gait markers that appear to distin | National Institutes of Health | 3/15/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $113,241 | Trans-NIH Recovery Act Research Support This administrative supplement requests personnel funding for a postdoctoral associate to accelerate research on a multiplex PCR based screening diagnostic for enteropathogens. The original peer-reviewed research program was budgetarily cut which required | National Institutes of Health | 8/16/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $110,601 | Trans-NIH Recovery Act Research Support Project Narrative Our supplement will address the intent of the American Recovery and Reinvestment Act of 2009 regarding our parent proposal to better understand the pathophysiology of acute kidney injury and identify novel therapeutic options. The upgrad | National Institutes of Health | 9/22/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $109,212 | Trans-NIH Recovery Act Research Support The Rural Health Care Center, funded by the National Institute of Nursing Research, provides an infrastructure necessary to conduct and disseminate research responsive to the health care needs of impoverished individuals, racial and ethnic minorities, and | National Institutes of Health | 7/14/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $108,000 | Trans-NIH Recovery Act Research Support This extension of the Framework Program in Global Health at the University of Virginia is designed (1) to develop courses and research experiences that enhance students' and faculty members' abilities to participate in global health research across discip | National Institutes of Health | 9/03/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $107,464 |
Trans-NIH Recovery Act Research Support Following the anthrax bioterror attacks in the US in 2001, awareness of the potentially devastating effects of attack with a bioweapon led to recognition of the need to take action and prepare against possible future nefarious events. F. tularensis was pl
This spending item is part of a $1,137,892 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| CHILDREN YOUTH & FAMILY SERVICE | $104,000 |
ARRA Child Care and Development Block Grant ARRA Supplemental Discretionary Grant Award. The award represents an additional Discretionary fund obligation to the State for fiscal year 2009 for the Child Care Development Fund.
This spending item is part of a $37,891,741 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $101,640 | Trans-NIH Recovery Act Research Support This is an administrative supplement to the parent R01 DK069769 grant Autoimmunity and Pathogenesis of Glomerulonephritis (GN). The project investigates factors responsible for progressive renal disease in Systemic Lupus Erythematosus (SLE) with special e | National Institutes of Health | 8/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $101,087 | Trans-NIH Recovery Act Research Support The cellular responses activated by TGF beta family signaling underlie many developmental and proliferative events, including mesoderm induction, dorsalization and anti proliferative responses in mammalian cells. TGIF is a transcriptional repressor which | National Institutes of Health | 6/24/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $100,299 | Trans-NIH Recovery Act Research Support The long-term goal of the proposed research is to better understand the molecular mechanisms that regulate RNA polymerase I (Pol I) transcription of ribosomal RNA. This rRNA becomes the major structural and functional component of ribosomes and its rate | National Institutes of Health | 12/11/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $100,000 | Trans-NIH Recovery Act Research Support The nature of the signals that regulate intestinal stem cells and mediate the establishment of this hierarchical organization of the epithelium during normal gastrointestinal development has not yet been defined. We have recently found that expression of | National Institutes of Health | 9/22/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $99,753 | Trans-NIH Recovery Act Research Support This administrative supplement under the American Recovery and Reinvestment Act is to update our spinning disk confocal microcope with a motorized stage and faster camera to facilitate both Aims of the parent grant. These microscope updates will greatly i | National Institutes of Health | 9/30/2009 |
| PLUROGEN THERAPEUTICS, INC | $99,615 | Trans-NIH Recovery Act Research Support Chronic wounds, such as diabetic wounds, are a major global health and economic burden. In the United States alone, 10.8 million chronic wounds occur every year (de Zoysa et al., 2005) which is estimated to cost over $15 billion annually in the U.S. (Farl | National Institutes of Health | 9/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $98,710 |
Trans-NIH Recovery Act Research Support Damage to inner ear hair cells is a leading cause of human deafness and balance disorders and affects >10% of the world's population. Mammals cannot regenerate their hair cells. However, birds (and other lower vertebrates) can regenerate these cells. This
This spending item is part of a $995,615 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $98,710 |
Trans-NIH Recovery Act Research Support Damage to inner ear hair cells is a leading cause of human deafness and balance disorders and affects >10% of the world's population. Mammals cannot regenerate their hair cells. However, birds (and other lower vertebrates) can regenerate these cells. This
This spending item is part of a $995,615 allocation.
See details
|
National Institutes of Health | 9/17/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $93,563 | Trans-NIH Recovery Act Research Support In chronic inflammation, the affected tissue undergoes an oxidative stress that exacerbates inflammation and contributes to tissue damage including DNA damage and cancer. One of the molecules regulating the cellular responses to oxidative stress is APE-1 | National Institutes of Health | 9/10/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $90,772 | Trans-NIH Recovery Act Research Support Supplementary funds are requested to purchase three items of equipment that are needed for research supported by this grant. Over the 24 years of funding of this grant there has been great difficulty in maintaining our equipment needs. One item requested | National Institutes of Health | 2/24/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $90,580 | Trans-NIH Recovery Act Research Support Hypothalamic gonadotropin releasing hormone (GnRH), controls production of luteinizing hormone (LH) and follicle stimulating hormone (FSH), LH regulating ovarian hormones and FSH gamete maturation. In normal ovulatory cycles, differential synthesis/secret | National Institutes of Health | 8/26/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $88,898 | Trans-NIH Recovery Act Research Support This application is submitted in response to NOT -OO-09-056NIH Announces the Availability of Recovery Funds for Administrative supplements. During the first 5 years of support for OK 57878 -Effect of insulin on the microvasculature, we investigated the | National Institutes of Health | 12/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $87,000 | Trans-NIH Recovery Act Research Support This administrative supplement under the American Recovery and Reinvestment Act is to purchase an SGA robot to facilitate both Aims of the parent grant. The SGA robot will enhace the speed and accuracy of genetic manipulations essential to completing both | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $86,733 | Trans-NIH Recovery Act Research Support The renin-angiotensin system (RAS) is the major regulator of body fluid and electrolyte homeostasis. It also contributes to development of variety of renal and cardiovascular diseases such as hypertension. (PRO)renin receptor is the newest component to be | National Institutes of Health | 9/18/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $86,632 | Trans-NIH Recovery Act Research Support Much of the recent progress in protein trafficking is due to new technical advances in live cell microscopy. We are requesting an equipment administrative supplement to upgrade an outmoded 1980's era microscope to a state of the art automated fluorescence | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $86,464 | Trans-NIH Recovery Act Research Support The Rural Health Care Research Center (RHCRC), an interdisciplinary research center located in the School of Nursing at the University of Virginia is funded by the National Institutes of Health National Institute of Nursing Research for the time period of | National Institutes of Health | 9/01/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $83,180 | Trans-NIH Recovery Act Research Support The University of Virginia has developed into a top-tier research and teaching institution in the area of molecular biophysics. A key component of this effort has been the development of outstanding research training programs particularly in the areas of | National Institutes of Health | 8/13/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $81,616 | Trans-NIH Recovery Act Research Support This project focuses on protein phosphatase-1 (PP1) and inhibitor-2 (Inh2) that localize to centrosomes and have essential and critical roles in mitosis. Understanding the role of these proteins in mitosis will impact the use of mitotic kinase inhibitors | National Institutes of Health | 7/15/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $75,449 | Trans-NIH Recovery Act Research Support We hypothesize that: (i) repeat vaccination with melanoma peptides and adjuvant may cause persistence of LNLA and creation of tertiary lymphoid organs at vaccine sites, (ii) extending immunization may result in a secondary set of immune regulatory influen | National Institutes of Health | 9/01/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $71,102 | Trans-NIH Recovery Act Research Support We propose an Administrative Supplement, under the Recovery Act (NOT-OD-09-056), to parent grant, NIH R37 HD025594, 'Cell Motility and Cell Interactions During Neurulation. The work proposed here will greatly accelerate and extend the progress, and enhanc | National Institutes of Health | 9/22/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $71,095 | Trans-NIH Recovery Act Research Support This request for a Recovery Act Administrative Supplement as per NIH Notice (NOT -00-09-056) will accelerate progress on, 1 ROl HD0535S0?01A1, Combinations of genetic and environmental risk for externalizing in adolescence. We are requesting funds to empl | National Institutes of Health | 8/18/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $67,007 |
Trans-NIH Recovery Act Research Support Following the anthrax bioterror attacks in the US in 2001, awareness of the potentially devastating effects of attack with a bioweapon led to recognition of the need to take action and prepare against possible future nefarious events. F. tularensis was pl
This spending item is part of a $1,137,892 allocation.
See details
|
National Institutes of Health | 9/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $65,832 |
Trans-NIH Recovery Act Research Support In the twenty-first century, cervical cancer prevention programs represent the expenditure of significant public health dollars. In anticipation of changes in cervical cancer prevention strategies such as first- and second- generation human papillomavirus
This spending item is part of a $2,421,152 allocation.
See details
|
National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $64,759 | Trans-NIH Recovery Act Research Support Mechanisms governing (a) normal gonadotropin-releasing hormone (GnRH) secretion across puberty and (b) abnormal GnRH secretion in peripubertal girls who go on to develop polycystic ovary syndrome (PCOS) are unclear. In the parent grant, we proposed a nove | National Institutes of Health | 7/19/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $64,230 | Trans-NIH Recovery Act Research Support The goal of this project is to investigate the signaling pathways controlled by mTOR, a highly conserved Ser-Thr phosphatidylinositol 3-kinase-related protein kinase. We recently demonstrated that the mTOR-mediated phosphorylation of raptor is required fo | National Institutes of Health | 1/15/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $63,000 | Trans-NIH Recovery Act Research Support A better understanding of genetic factors that influence the severity of cerebral palsy (CP) in children or their role in repair and recovery could lead to new, innovative treatments that mitigate disability and improve functional outcomes. Apolipoprotein | National Institutes of Health | 9/02/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $61,600 | Trans-NIH Recovery Act Research Support Adult to adult living donor liver transplantation (LDL T) was introduced in the United States in 1998 following its development in Asia. Surprisingly, the application of this approach to transplantation in the U.S. grew considerably, reaching approximatel | National Institutes of Health | 2/03/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $61,195 | Trans-NIH Recovery Act Research Support An Administrative Supplement is requested to purchase a fast protein liquid chromatography (FPLC) system for purification of the Gal/GalNAc lectin of Entamoeba histolytica. The purified Gal/GalNAc lectin produced by this FPLC system will be used in the v | National Institutes of Health | 5/17/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $59,950 | Trans-NIH Recovery Act Research Support Supplemental funding is requested to enhance our ability to image live epithelial cysts growing in 3D Matrigel cultures (existing Aim 1); to extend our ongoing screen for genes involved in tight junction formation and apicallbasal polarization of epitheli | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $59,480 |
Trans-NIH Recovery Act Research Support Our Center for the Structural Biology of Cellular Host Elements in Egress, Trafficking, and Assembly of HIV CHEETAH studies the structural biology of HIV/Host interactions involved in viral trafficking and assembly. Here, we request funds that will enabl
This spending item is part of a $467,025 allocation.
See details
|
National Institutes of Health | 9/25/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $54,000 | Trans-NIH Recovery Act Research Support The main goal of the parent grant that will benefit from the Administrative Supplement is to define the role of renin during the differentiation of ectodermal precursors into their derivative tissues (Le. skin., choroid plexus, sympathetic ganglia, adren | National Institutes of Health | 12/21/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $50,803 | Trans-NIH Recovery Act Research Support The supplement requests support to examine the light and ultrastructural localization of TSKS during both mouse and human spermatogenesis. As part of these studies co-localizations of TSKS with markers of centrioles and chromatoid bodies would be examined | National Institutes of Health | 7/21/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $50,000 | Trans-NIH Recovery Act Research Support The Cancer Center will participate in planning activities associated with project ADOPT by providing the clinical and informatics expertise of two staff members in scheduled meetings and conference calls for the duration of the project period. | National Institutes of Health | 9/29/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $50,000 | Trans-NIH Recovery Act Research Support The Ligand Core has used the Immulite 1000 automated immunoassay analyzer to measure reproductive hormones in human clinical research samples over the past 8 years. The increase in assays needed for samples associated with new A/B projects over the next y | National Institutes of Health | 9/22/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $50,000 | Trans-NIH Recovery Act Research Support Tile parent grant of this proposal, Adenosine A2a Receptor Agonist in Diabetic Nephropathy, was designed to study the anti-inflammatory, hemodynamic and antiproteinuric effects of A2a agonist in individuals with type 2 diabetes and nephropathy as compare | National Institutes of Health | 12/22/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $47,680 | Trans-NIH Recovery Act Research Support This suplement involves the recruitment of a middle school science teacher to perform food allergy reseach in the laboratory during the summer months. Food allergy is a significant public health problem. The cause for the disease is poorly understood and | National Institutes of Health | 6/04/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $47,000 | Trans-NIH Recovery Act Research Support This supplement is to purchase new instrumentation for the Ligand Core Lab. This Core provides assay services to NIH-supported investigators both within UVA, as well as all Reproductive Sciences Branch-supported Reproductive Centers across the country. Th | National Institutes of Health | 8/26/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $46,273 | Trans-NIH Recovery Act Research Support Summer research training will be provided to high school students, undergraduate, and high school science science educators interested in contraceptive target identification, validation and drug development. Each of the four laboratories involved in this | National Institutes of Health | 6/19/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $45,228 | Trans-NIH Recovery Act Research Support The supplement requests support to train one high school, one graduate student and one science educator during the summer of 2010. Students or educators who have the opportunity to work on aspects of the above noted project will learn molecular biology, b | National Institutes of Health | 5/06/2010 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $41,236 | Trans-NIH Recovery Act Research Support We seek one additional training slot for the Biotechnology Training Program (BTP) at UVa. In the first nine (9) years of funding, we built the BTP into a highly interactive community of Ph.D. trainees drawn selectively from an annual spring competition o | National Institutes of Health | 8/31/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $35,115 | Trans-NIH Recovery Act Research Support This ARRA funding makes possible the extension of our ApoE studies into an infection model, relevant to a major threat to the cognitive development and growth of the young child by repeated enteric infections. We will examine the relevance of malnutrition | National Institutes of Health | 9/30/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $32,330 | Trans-NIH Recovery Act Research Support An Administrative Supplement is requested to support two undergraduate students. These students will conduct research on the parasite Entamoeba histolytica. They will have project that support the specific aims of the grant: 5 RO1 AI026649-20 Structure an | National Institutes of Health | 6/04/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $32,213 | Trans-NIH Recovery Act Research Support Attraction of students to scientific research is a central element in maintaining the quality of and quantity of science in the United States. College students have reached a level of knowledge and skill and have begun to consider their career plans so th | National Institutes of Health | 6/04/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $30,000 |
Trans-NIH Recovery Act Research Support This supplemental application for the UAB-UCSD O'Brien Core Center for Acute Kidney Injury (AKI)(1P30 DK079337) in response to NIDDK FY2009 Program for Administrative Supplements Utilizing Recovery Act Fund (NOT-OD-09-056) is designed to facilitate new an
This spending item is part of a $363,337 allocation.
See details
|
National Institutes of Health | 8/10/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $29,856 |
Trans-NIH Recovery Act Research Support Few studies have examined the relationship with gene on the DNA repair and apoptosis pathways. Our preliminary data support associations with several single nucleotide polymorphism in genes in these pathways but a larger sample size is needed to confirm t
This spending item is part of a $1,563,767 allocation.
See details
|
National Institutes of Health | 8/04/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $28,028 | Trans-NIH Recovery Act Research Support Microvascular growth (angiogenesis) and remodeling impacts many tissue repair processes in the postnatal organism and plays a critical role in a number of human diseases, including tumorgenesis, diabetes, and ischemic disorders of the lower limbs and coro | National Institutes of Health | 6/01/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $25,000 | Trans-NIH Recovery Act Research Support This proposal is a request for an Administrative Supplement for a multi-PI grant, (1 R01 GM08457-01A1) entitled Molecular Mechanisms of RhoA-mediated Ca2+ Sensitization in Vascular Smooth Muscle; the corresponding proposal received a priority score of 110 | National Institutes of Health | 7/16/2010 |
| University of Virginia Medical Center | $23,443 |
ARRA - Preventing Healthcare-Associated Infections The program for healthcare-associated infection (HAI) surveillance and prevention in Virginia involves a partnership between the Virginia Department of Health (VDH) and other agencies with the primary goals of: (1) Hiring support staff for HAI prevevention... Show more
This spending item is part of a $1,063,554 allocation.
See details
|
Centers for Disease Control and Prevention | 8/28/2009 |
| RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | $13,500 |
Trans-NIH Recovery Act Research Support It is estimated that 3.2 million African Americans aged 20 years or older have type 2 diabetes. This represents approximately 13% of the AA population and a significant proportion of the more than 20 million Americans believed to be living with diabetes,
This spending item is part of a $143,505 allocation.
See details
|
National Institutes of Health | 7/26/2010 |
| VIRGINIA COMMUNITY COLLEGE SYSTEM OFFICE | $900 |
ARRA Child Care and Development Block Grant ARRA Supplemental Discretionary Grant Award. The award represents an additional Discretionary fund obligation to the State for fiscal year 2009 for the Child Care Development Fund.
This spending item is part of a $37,891,741 allocation.
See details
|
Administration for Children and Families | 4/09/2009 |